FSD Pharma Inc.
CCSE:HUGEShare Statistics
As of June 30, 2024, FSD Pharma Inc. has 729,360.00 shares outstanding.
| Shares Outstanding | 729,360.00 |
Valuation Ratios
These figures are as of June 30, 2024.
| PB Ratio | -0.40 |
| P/TBV Ratio | 1.75 |
| P/FCF Ratio | -1.72 |
| P/OCF Ratio | -1.72 |
Financial Position
As of June 30, 2024, FSD Pharma Inc. maintains a current ratio of 1.99, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.13, indicating elevated leverage, while an interest coverage ratio of -500.96 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.99 |
| Quick Ratio | 1.96 |
| Debt / Equity | 6.13 |
| Debt / EBITDA | -0.06 |
| Interest Coverage | -500.96 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2024. Return on assets (ROA) is negative at -40.76, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -40.76 |
Dividends & Yields
These figures cover the twelve months ended June 30, 2024. Free cash flow yield is negative at -58.20: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -26.40, meaning FSD Pharma Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -26.40 |
| FCF Yield | -58.20 |
Stock Splits
FSD Pharma Inc.'s most recent stock split took place on October 17, 2019 with a 201:1 split ratio.
| Last Split Date | 10/17/2019 |
| Split Ratio | 201:1 |
Scores
As of June 30, 2024, FSD Pharma Inc. has an Altman Z-Score of -24.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -24.51 |